[Catch up on Cytodyn’s seemingly doomed quest for a NASDAQ listing here, and click here to learn more about who is participating in the much hyped CD12 trial of loserlimab.]

Back in late April, we looked at two rather interesting lawsuits filed against everyone’s favorite reverse-merger pink sheet Coronacrapper, Cytodyn (CYDY). Both of those suits were filed by former insiders against the company and current management.

Just last week another suit was filed against Cytodyn. In this one, Florida Circuit Court of Miami Dade County Case 2020-020074-CA-01 (available here) Shift Media Lab is suing Cytodyn for failure to pay its bills.

So who is Shift Media Lab, and what were they doing for Cytodyn? There isn’t much about Shift on the interwebs. According to the complaint they were engaged to provide “services” to Cytodyn for three months at $25,000 per month.

And just what might those “services” have been? If one looks carefully at Cytodyn’s disclosure statement to OTC Markets, Shift appears in the rogues’ gallery of what can kindly be described as stock promoters.

Is there a term for disgruntled not-paid promoters?

THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.